In one of the pioneering genetic studies of acne, it has been seen that the condition that affects millions of teenagers and adults could have a genetic basis. This genetic study can also pave the way for new and accurate treatment for acne promise researchers. The study results are published in the latest issue of […]
A discovery by researchers from the School of Basic & Medical Biosciences and NIHR Guy’s and St Thomas’ Biomedical Research Centre could lead to new treatments for severe acne. Scientists found 15 genome regions linked to developing the condition.
Many people with acne are negatively impacted by perceived social stigma around the skin condition, a new study from University of Limerick, Ireland, has found.
Being a teenager can be tough. Teens must manage high school and the pressures of adolescence while at the same time battling stubborn acne.
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.
Topical retinoids, which target retinoic acid receptors, are commonly used to treat acne. New research published in theBritish Journal of Dermatologyreveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety profile compared with less selective retinoids.
In a finding that suggests the potential for practice change that would reduce the use of antibiotics in dermatology, researchers in the Perelman School of Medicine at the University of Pennsylvania have found the diuretic drug spironolactone may be just as effective as antibiotics for the treatment of women’s acne.
In an analysis of one of the largest electronic medical records databases in the world, researchers found that patients with acne had a significantly increased risk of developing major depression, but only in the first 5 years after being diagnosed with acne.
A Canadian clinical trial led by researchers at the University of Calgary’s Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.